Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

Alexandra JobertEdouard-Jules LaforgueMarie Grall-BronnecMorgane RousseletMorgane PéréPascale Jollietnull nullFanny FeuilletCaroline Victorri-Vigneau

Published in: European journal of clinical pharmacology (2020)

Our study identifies a specific population experiencing withdrawal symptoms and who cannot stop administering BZD/Z-drug. We assume that withdrawal symptoms in patients with chronic use play an essential role in the nonstop use of BZD/Z-drugs.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
sleep quality
gene expression
physical activity
drug induced
patient reported